Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Boston Scientific Corp. (NYSE: BSX).

Full DD Report for BSX

You must become a subscriber to view this report.


Recent News from (NYSE: BSX)

AtriCure Is An Interesting Buy In December 2018
Having the only PMA product for the surgical treatment of atrial fibrillation (or Afib), AtriCure ( ATRC ) is today looking at a highly underserved market opportunity. It is estimated that 17 million patients across the world and 6 million in the U.S. suffer from Afib, of which, a wide major...
Source: SeekingAlpha
Date: December, 14 2018 17:03
The S&P 500 And You: Why Most Investors Did Not Beat The Market In 2018
Underperformed your benchmarks this year? There are quite a few reasons why that likely occurred – most of which are reoccurring. As we get into the close of what has been a very tough Q4, I wanted to disseminate the data I generally put together each December on S&P 500 ( SPY ) c...
Source: SeekingAlpha
Date: December, 14 2018 13:24
Penumbra Should Shine Brighter
I loved just about everything about Penumbra ( PEN ) except the price/upside when I last wrote about this fast-growing neurovascular med-tech company. Since then, the company has continued to sail past sell-side expectations, but the market has gotten more risk-averse and worries have crop...
Source: SeekingAlpha
Date: December, 12 2018 10:34
Boston Scientific Prevails in U.S. Edwards Lifesciences Litigation
MARLBOROUGH, Mass. , Dec. 11, 2018 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced that a jury in the United States (U.S.) District Court for the District of Delaware determined that the Boston Scientific U.S. patent 8,992,608 is valid and that Edwards Lifesc...
Source: PR Newswire
Date: December, 11 2018 18:13
Research Report Identifies CoreLogic, Altisource Portfolio Solutions S.A, Old Dominion Freight Line, Emerson Electric, Boston Scientific, and Natural Grocers by Vitamin Cottage with Renewed Outlook - Fundamental Analysis, Calculating Forward Movement
NEW YORK, Dec. 07, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of CoreLogic, Inc. (NYSE:CLGX), Altisource Portfolio Solutions S.A. (NASDAQ:...
Source: GlobeNewswire
Date: December, 07 2018 07:40
Boston Scientific Corporation (BSX) Management on Citi's 2018 Global Healthcare Conference Call (Transcript)
Boston Scientific Corporation (BSX) Citi's 2018 Global Healthcare Conference Call December 6, 2018 09:30 ET Executives Arthur Butcher - SVP & President, Endoscopy Susan Lisa - IR Analysts Amit Hazan - Citi Presentation Amit Hazan I'm Amit Hazan, the medical devi...
Source: SeekingAlpha
Date: December, 06 2018 16:32
Today's Research Reports on Trending Tickers: Boston Scientific and Abbott Laboratories
NEW YORK, NY / ACCESSWIRE / December 6, 2018 / U.S. markets fell in Tuesday amidst trade related uncertainty between the U.S. and China. The Dow Jones Industrial Average fell 3.10 percent to close at 25,027.07, while the S&P 500 Index decreased 3.24 percent to close at 2,700.06. The Nas...
Source: ACCESSWIRE IA
Date: December, 06 2018 07:50
Boston Scientific to Participate in 2018 BMO Capital Markets Prescriptions for Success Healthcare Conference
MARLBOROUGH, Mass. , Dec. 3, 2018 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in the 2018 BMO Capital Markets Prescriptions for Success Healthcare Conference on Wednesday, December 12, 2018 in New York City . Susie Lisa , vice president, Investor Relat...
Source: PR Newswire
Date: December, 03 2018 09:30
Boston Scientific to Participate in Citi's 2018 Global Healthcare Conference
MARLBOROUGH, Mass. , Nov. 27, 2018 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in Citi's 2018 Global Healthcare Conference on Thursday, December 6, 2018 in New York City . Art Butcher , senior vice president and president, Endoscopy and ...
Source: PR Newswire
Date: November, 27 2018 09:30
Emergence of Advanced Electrocardiographic Technologies Show Major Promise for Electrophysiology (EP) Industry
November 27, 2018 Palm Beach, FL – (November 27, 2018) – The cardiology market within the biotech industry is being revitalized by advancements of Electrocardiographic technologies. North America dominates the global multi-lead Electrocardiographic machines market due to ri...
Source: Financial News Media
Date: November, 27 2018 08:15

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-0836.3235.8536.3835.814,512,502
2018-05-1729.9530.3230.48529.847,304,374
2017-11-0827.8228.1028.1327.647,645,584
2017-11-0727.9327.9627.9827.744,884,141
2017-11-0627.8527.8127.9027.607,662,024

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1448,891271,52618.0060Cover
2018-12-1322,23077,95428.5168Cover
2018-12-1245,216195,16823.1677Cover
2018-12-1131,916101,99331.2923Cover
2018-12-1033,094112,84529.3270Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on BSX.


About Boston Scientific Corp. (NYSE: BSX)

Logo for Boston Scientific Corp. (NYSE: BSX)

Not available

 

Contact Information

 

 

Current Share Structure

  • Market Cap: $41,352,920,745 - 05/11/2018
  • Issue and Outstanding: 1,379,810,502 - 04/25/2018

 


Recent Filings from (NYSE: BSX)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 11 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 01 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 25 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: April, 10 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: March, 28 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: March, 28 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 22 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: February, 26 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: February, 23 2018
Prospectus filed under Rule 424(b)(2)
Filing Type: 424B2Filing Source: edgar
Filing Date: February, 23 2018

 

 


Daily Technical Chart for (NYSE: BSX)

Daily Technical Chart for (NYSE: BSX)


Stay tuned for daily updates and more on (NYSE: BSX)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NYSE: BSX)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in BSX is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of BSX and does not buy, sell, or trade any shares of BSX. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/